Skip to content
Screener

AN2 Therapeutics, Inc. ANTX Q2 2026 earnings

Reported August 11, 2026 · After market close

EPS-$0.18Beat by $0.06
EPS estimate-$0.24

Next report

Nov 5, 2026 (in 2 months)
EPS estimate-$0.20

FAQ

When did AN2 Therapeutics, Inc. report Q2 2026 earnings?
AN2 Therapeutics, Inc. (ANTX) reported Q2 2026 earnings on August 11, 2026 after market close.
What were AN2 Therapeutics, Inc.'s Q2 2026 revenue and EPS?
AN2 Therapeutics, Inc. reported eps of $-0.18 for Q2 2026.
Did AN2 Therapeutics, Inc. beat estimates in Q2 2026?
EPS beat the consensus estimate of $-0.24 by $0.06.
How did AN2 Therapeutics, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 14.3% from $-0.21.
Where can I find AN2 Therapeutics, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-344549) and the 10-Q periodic report (0001193125-26-344569) directly on SEC EDGAR. The filing index links above go to sec.gov.